Application of GYY4137 in preparation of drugs for inhibiting pyroptosis of vascular endothelial cells
A 1.GYY4137, vascular endothelium technology, applied in the field of biomedicine, can solve problems such as aggravating vascular inflammation and damage to arterial structure and function
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] 1 material
[0038] 1.1 Cell Human umbilical vein endothelial cells (Human umbilical vein endothelial cells, HUVECs) were purchased from American Type Culture Collection (ATCC) laboratory.
[0039] 1.2 Drugs and reagents Special culture medium for endothelial cells and fetal bovine serum were purchased from Sciencell, USA; oxidized low-density lipoprotein (oxLDL) was purchased from Guangzhou Yiyuan Biotechnology Co., Ltd. Homocysteine (Hcy), lipopolysaccharide (LPS ), H 2 S donor GYY4137 and endogenous H 2 S synthase inhibitor DL-propargylglycine (D,L-propargylglycine, PAG) was purchased from Sigma-Aldrich, USA; CCK-8 cell viability detection kit was purchased from Dongren Chemical Technology (Shanghai) Co., Ltd.; Hoechst33342 / Propidium iodide (PI) double staining kit and lactate dehydrogenase (lactate dehydrogenase, LDH) cytotoxicity detection kit were purchased from Nanjing Jiancheng Bioengineering Institute; Caspase-1 activity detection kit was purchased from Sh...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com